Evaro, founded in 2017 and headquartered in the United Kingdom, represents an innovative force in the intersection of the Health Care and Platforms industries. The company's compelling slogan, "We power your leap into digital health and connect more customers to the care they need," highlights its mission to enhance accessibility and improve health outcomes through digital means.
Evaro offers a unique turnkey solution that empowers brands to integrate prescription medication services seamlessly into their offerings with just a single line of code. This approach allows brands to easily enter the digital health space while Evaro manages all aspects of technology, regulation, fulfillment, and aftercare.
The company has recently secured a $25.00M Series A investment on 27 January 2026, underscoring investor confidence in its growth potential. Notable investors in this round include Cornerstone VC, Exceptional Ventures, AlbionVC, Simplyhealth Ventures, and BBI.